Suppression of NR0B2 gene in Clear Cell Renal Cell Carcinoma Is Associated with Hypermethylation of Its Promoter

• Published in: Molecular biology (New York) Vol. 52; no. 3; pp. 414 - 418
• Main Authors: Kudryavtseva, A. V., Nyushko, K. M., Zaretsky, A. R., Shagin, D. A., Sadritdinova, A. F., Fedorova, M. S., Savvateeva, M. V., Guvatova, Z. G., Pudova, E. A., Alekseev, B. Y., Dmitriev, A. A., Snezhkina, A. V.
• Format: Journal Article
• Language: English
• Published: Moscow Pleiades Publishing 01.05.2018; Springer Nature B.V
• Subjects: Biochemistry; Biomedical and Life Sciences; Clear cell-type renal cell carcinoma; Gene regulation; Human Genetics; Kidney cancer; Life Sciences; Malignancy; Molecular Cell Biology; Transcription; Tumor suppressor genes; Tumors; DNA methylation; clear cell renal cell carcinoma; bisulfite sequencing; quantitative PCR; tumor suppressor gene
• ISSN: 0026-8933; 1608-3245
• DOI: 10.1134/S0026893318030081

Clear cell renal cell carcinoma (ccRCC) is a common urologic malignancy. Understanding of the transcriptional regulation of oncogenes and tumor suppressor genes involved is critical for the development of the treatments for renal tumors. Using ccRCC subdivision of the TCGA dataset, we identified NR0B2 encoding orphan nuclear receptor as a tumor suppressor candidate in renal tissue. In independent cohort of primary renal tumors, quantitative PCR experiments confirmed significant suppression of NR0B2 mRNA in 86% of ccRCC samples studied. In 80% of these cases, we detected the hypermethylation of the NR0B2 promoter region. These results suggest that NR0B2 is a tumor suppressor gene in ccRCC, and that the hypermethylation of promoter region is the main mechanism of its downregulation.